We are live on
!
Find out more
DMTX
Dimension Therapeutics, Inc
DMTX
DMTX
Delisted
DMTX was delisted on the 6th of November, 2017.
40 hedge funds and large institutions have $169M invested in Dimension Therapeutics, Inc in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 9
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less funds holding
Funds holding: 41 → 40 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
30% less capital invested
Capital invested by funds: $242M → $169M (-$73.2M)
Holders
40
Holders Change
-1
Holders Change %
-2.44%
% of All Funds
1.07%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
15
Reduced
9
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$3.62M |
| 2 |
AG
Artal Group
Luxembourg
|
+$788K |
| 3 |
JP Morgan Chase
New York
|
+$632K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$465K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$405K |
Top Sellers
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.86M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.26M |
| 3 |
Goldman Sachs
New York
|
-$1.23M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$710K |
| 5 |
Norges Bank
Oslo,
Norway
|
-$564K |
